Catalyst Wire Dossier Catalyst Wire Dossier

AuraClens

· Tiger Biosciences, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AuraClens, covering 2026-08-05 to 2026-08-05. Get the full timeline:

Most recent: Clinical Trial Results: AuraClens™ System in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast [NA]

See pricing